1Jacobson MD. Weil M, Raff MC. Programmed cell death in animal development[J]. Cell. 1991,65: 1097-1105.
2Noble BS. Steven h. Loveridge N,et al. Identification of apoptotic changes in osteocytes in normal and pathological human bone[J]. Bone. 1997,20(3) :273-282.
3Einhom TA. The cell and molecular biology of fracture healing [J]. Clin Orthop. 1998, ( 355suppl ): s 7-21.
4Oltavai ZN,Milliman CL,Korsmeyer SJ. Bcl-2 hetcrodimerizcs in vivo with a conservcd homolog Bax.that acelerates programmed cell dcath[J]. Cell. 1993,74:609-619.
5Hill PA Tumbor A. Meikle MC. Multiple extraccllular signals promote ostcoblast survival and apoptosis[J].Endocrinology. 1997,138(9) :3849-3858.
7Schacht E. Rationale for treatment of involutional;osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcido [J]. Calcif-Tissue-Int. 1999,65(4):317-327.
8Noble BS,Reeve J. osteocyte function,oseocyte death and bonc fracture resistance [J]. Mol-Cell-Endocrinal, 2000,159 ( 1-2): 7-13.
9Damoulis PD. Hauschka PV. Nitric oxide act in conjuction with proinflammatory cytokincs to promete cell death in ostcoblast[J]. j-Miner-Res. 1997,12(3):412-422.
10Verborgt O,Gibson GJ,Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone rcmodeling after fatigue in vivo[J]. J-BoneMiner-Res. 2000,159(1-2):7-13.
